If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBio-Sustainable Future Enterprises Regulatory News (BSFA)

Share Price Information for Bio-Sustainable Future Enterprises (BSFA)

Share Price is delayed by 15 minutes
Get Live Data
0.90    -0.002 (-0.22%)
Bid:
0.80
Ask:
1.00
Spread: 0.20 (25.00%)
Market Cap: £1.74m
BSFA Live PriceLast checked at - London Stock Exchange

Intraday Bio-Sustainable Future Enterprises Share Chart

Acquisition

16 Jul 2020 07:48

RNS Number : 2016T
BSF Enterprise PLC
16 July 2020
 

 

 

BSF Enterprise PLC

 

 

 

C/o Locke Lord LLP201 BishopsgateLondon EC2M 3AB

 

16 July 2020

 

 

BSF Enterprise Plc (the "Company")‎

 

Proposed extension of acquisition period and strategy

General Meeting

 

Since its admission to ‎the London Stock Exchange and ‎the Official List of the UK Listing Authority (standard segment), the Company has focused on identifying and pursuing acquisition targets within the innovation marketing and technology sector further to the Company's acquisition criteria as described in its prospectus dated 19 July 2019 ("Prospectus").

 

In line with the statements contained in its Prospectus, if an acquisition had not been announced within 12 months of admission (which took place on 26 July 2019), the board of directors (the "Board") must recommend to shareholders that the Company continue to pursue an acquisition for a further 12 months from the first anniversary of admission or that the Company be wound up (in order to return capital to shareholders to the extent assets are available). The Board's recommendation must then be put to a shareholder vote from which the Directors will abstain.

 

In light of the current economic climate against the backdrop of the global Covid-19 pandemic, the Board considers it is in the best interests of the Company's shareholders that the Company both continue to seek acquisitions for a further 12 months and broaden the sector focus of targeted acquisitions to include biotechnology and life sciences in order to take advantage of one or more acquisition opportunities which the Board believes will be available to the Company in the near-term.

 

Accordingly, the Company is convening a general meeting of the Company to be held at 11.30 am on Monday, 3 August 2020 at which the Board will recommend shareholders to approve the proposed extension of the acquisition period and strategy. The Directors will abstain from voting at the general meeting.

 

A circular including a notice convening the General Meeting will be despatched to shareholders today and will be available after publication on the Company's website at www.bsfenterprise.com 

 

 

** ENDS **

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Following the publication of this announcement, this inside information is now considered to be in the public domain.

LEI: ‎ 2138007PJT69H8FYLC06 ‎

Geoff Baker

Company Secretary ‎

geoffbaker@asfgroupltd.com.‎

BSF Enterprise PLC

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQEAKXKFLFEEEA
Date   Source Headline
20th Feb 20233:00 pmRNSNotice of AGM
10th Feb 20237:00 amRNSAllotment of shares
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20232:05 pmRNSSecond Price Monitoring Extn
1st Feb 20232:00 pmRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSUK’s First Fillet of Cultivated Meat Produced
31st Jan 20234:36 pmRNSAnnual Report and Financial Statements
19th Dec 20227:00 amRNS3D Bio-Tissues enters partnership with New Harvest
23rd Nov 20224:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNS3D Bio-Tissues partners with cell growth company
15th Nov 20227:00 amRNSSuccessful Prototypes of Lab-Grown Fillets of Meat
27th Oct 20227:00 amRNS3D Bio-Tissues receives €100,000 grant
21st Sep 20227:00 amRNS3D Bio-Tissues Appoints Business Director
18th Jul 20227:00 amRNSOperational Update
12th Jul 202212:08 pmRNSResults of Annual General Meeting
29th Jun 20227:00 amRNSInterim Financial Statements
17th Jun 20221:43 pmRNSNotice of Annual General Meeting
6th Jun 202210:42 amRNSAppointment of new CFO and opening London Office
17th May 20228:00 amRNSAdmission to Trading and First Day of Dealings
16th May 202210:46 amRNSResults of General Meeting
27th Apr 202212:07 pmRNSConditional Placing to raise £1.75 million
14th Feb 20224:52 pmRNSAnnual Financial Report
24th Dec 202110:58 amRNSAcquisition
16th Aug 20218:13 amRNSProposed Transaction and Suspension of Listing
16th Aug 20217:30 amRNSSuspension - BSF Enterprise Plc
9th Aug 20217:00 amRNSAppointment of Director
4th May 20212:44 pmRNSHalf-year Report
23rd Apr 202112:13 pmRNSHalf-year Report
6th Apr 20218:37 amRNSCorrection Statement
1st Apr 20214:56 pmRNSAGM Statement
1st Apr 20214:54 pmRNSResult of AGM
1st Apr 20217:00 amRNSAnnual Financial Report
1st Apr 20217:00 amRNSNotice of AGM
4th Mar 20213:19 pmRNSAGM Statement
4th Aug 20207:00 amRNSResult of General Meeting 
16th Jul 20207:48 amRNSAcquisition
31st Mar 20207:00 amRNSResult of AGM
26th Mar 202010:49 amRNSNotice Of AGM
3rd Mar 20204:10 pmRNSNotice of Annual General Meeting 2020
3rd Feb 20207:00 amRNSAnnual Financial Report
26th Jul 20198:31 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.